Peter De Muth Angion Biomedica Corp. (ANGN) insider trading activity
Peter De Muth is Chief Scientific Officer of Angion Biomedica Corp.. Currently has a direct ownership of 743 shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2025, when has been sold 362 shares (Common Stock) at a price of $4.41 per share, resulting in proceeds of $1,596. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
743
95.01%
3M change
95.01%
12M change
Total Value Held
$0
Peter DeMuth Transaction History
PD
Peter De Muth
Chief Scientific Officer
Boston, MA